Clinical Overview of MDM2/X-Targeted Therapies
Andrew Burgess, Kee Ming Chia, Sue Haupt, David Thomas, Ygal Haupt, Elgene Lim
FRONTIERS IN ONCOLOGY | FRONTIERS MEDIA SA | Published : 2016
AB is a CINSW FRL fellow (10/FRL/3-02). KC is an NHMRC Dora Lush Scholar. DT and YH are NHMRC principal research fellows (APP1104364 and APP9628426, respectively). EL is an NBCF/VCA practitioner fellow (PRAC14-002). This work was supported by the Patricia Helen Guest fellowship and Love Your Sister foundation. The funders had no role in analysis, decision to publish, or preparation of the manuscript.